Evaluation of host and tumor related metabolic asset as possible predictive and prognostic factors in early breast cancer patients candidate to neoadjuvant therapy

Keyphrases

1. Metabolic 100%
2. Neoadjuvant Therapy 75%
3. Breast Cancer Patients 50%
4. Gene Signature 50%
5. Personalized Treatment 50%
6. Immune Gene Expression 50%
7. Prognostic Algorithm 25%
8. Plasma Metabolomics 25%
9. Adjuvant Setting 25%
10. Early Identification 25%
11. Treatment Strategy 25%
12. Design Futures 25%
13. Pathological Features 25%
14. Adjuvant Therapy 25%
15. Treatment Response 25%
16. Breast Cancer 25%
17. Neoadjuvant 25%
18. Strong Predictor 25%
19. Tumor Samples 25%
20. Tumor-associated 25%
21. Long-term Prognosis 25%
22. Multivariable 25%
23. Multicentric 25%
24. Pathological Complete Response 25%
25. Treatment Options 25%
26. Expected Outcomes 25%
27. Predictive Algorithm 25%
28. Metabolomics 25%
29. Patient Treatment 25%
30. Mass Spectrometry Analysis 25%
31. Prognostic Stratification 25%
32. Integrated Tool 25%
33. Expected Impact 25%
34. Additional Treatment 25%
35. Non-responders 25%
36. Prognostic Prediction Model 25%
37. Multi-biomarker Approach 25%
38. Patient Selection 25%
39. Treatment Modulation 25%